1. Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company [Internet]. London: Financial Times; 2023 Sep 4 [cited 2023 Sep 28]. Available from: https://www.ft.com/content/19357584-62e0-452f-a06f-7cda1d8cd0e3.
2. Once-weekly semaglutide in adults with overweight or obesity;Wilding;N Engl J Med,2021
3. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial;Davies;Lancet,2021
4. Diabetes and obesity are rising globally—but some nations are hit harder [Internet]. London: Nature; 2023 Mar 7 [cited 2023 Sep 28]. Available from: https://www.nature.com/articles/d41586-023-00676-z.
5. Weight-loss injections have taken over the internet. But what does this mean for people IRL? [Internet]. Cambridge: MIT Technology Review; 2023 Mar 20 [cited 2023 Sep 28]. Available from: https://www.technologyreview.com/2023/03/20/1070037/weight-loss-injections-societal-impact-ozempic/.